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of IL12, which is far higher in XCR1+ DCs
than in other DC types, may also be
important. It is also likely that XCR1+
DCs express a unique set of chemokines
and chemokine receptors, maybe
including XCR1 itself, that determines
their function. It will be important to
investigate how this new model for
T cell help applies to other CD8+ T cell
responses, including anti-tumor re-
sponses.
A key step for future research will
certainly be to unravel the role of DC
subpopulations during the initiation of
immune responses in humans. Both
T cell and DC lineage organizations are
conserved between human and mice.
However, in both cases, the functions of
the subsets seem to have evolved differ-
ently. CD4+ human T cells are often cyto-
toxic, and it is still unclear if the human1212 Cell 162, September 10, 2015 ª2015 Ellineage homologs of XCR1+ DCs, which
express BDCA3+ and CD141+, cross-
present antigens more efficiently than
other DC subsets. In addition, the produc-
tion of IL-12 is clearly not restricted to the
human CD141+ DCs. Determining which
human DC, if any, functions as a ‘‘T cell
help platform’’ will certainly be a major
challenge in the next years and an essen-
tial step toward designing effective CD8+
T cell vaccines.
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In this issue, Farez et al. report that the circadian hormone melatonin, whose levels vary with sea-
sonal changes in night length, shifts the immune response toward an anti-inflammatory state that
may explain the seasonal variability of multiple sclerosis disease activity.An imbalance between the inflammatory
and regulatory responses of the immune
system can lead to chronic immune cell
activation and autoimmunity. Mounting
evidence implicates the Th17 subset of
T helper cells, characterized by the pro-
duction of the proinflammatory cytokine
interleukin-17 (IL-17), with playing a cen-
tral role in autoimmune diseases,
including multiple sclerosis (MS), rheu-
matoid arthritis (RA), psoriasis, and in-
flammatory bowel disease (IBD) (Gaffen
et al., 2014). Predominantly located at
barrier tissues that interface with the
external world, Th17 cells maintain a
high degree of flexibility to respond
rapidly to constant fluctuations in envi-
ronmental conditions and stimuli. Themechanisms that allow the adaptation
of Th17 cells to the ever-changing envi-
ronment include the ability to respond to
changing nutrient status through the aryl
hydrocarbon receptor (AHR) (Quintana
et al., 2008), to oxygen sensing path-
ways including HIF1a (Dang et al.,
2011), and to changes in osmotic pres-
sure through serum/glucocorticoid regu-
lated kinase 1 (SGK1) (Wu et al., 2013).
In this issue of Cell, Farez et al. (2015)
uncover another environmental cue—
seasonal changes in daylight—that
modulates the development of patho-
genic Th17 cells. The daylight effect is
mediated by the hormone melatonin,
produced by the pineal gland and
involved in the regulation of the circa-dian rhythm (Brzezinski, 1997). Mela-
tonin inhibits the development of proin-
flammatory Th17 cells and shifts the
balance of the immune response toward
immunosuppression.
It has been known for some time that
the latitudinal gradient—the greater the
distance from the equator— correlates
with increasing occurrence of multiple
sclerosis (Alonso and Herna´n, 2008).
One of the phenomena linked to latitude
is seasonal variation in exposure to UV
radiation. There are convincing epidemi-
ological data supporting the role of UV
radiation-dependent vitamin D in
reducing the disease course of MS
(Munger et al., 2004). Yet, this correlation
does not explain the increase in MS
Figure 1. Melatonin Shifts the Balance from Th17 to Tr1
(A) Depicted is a schematic of the melatonin signaling pathway resulting in the inhibition of Rorc. (1) Melatonin signals through the melatonin receptor MTNR1A
and results in ERK 1/2 phosphorylation. (2) Phosphorylated ERK 1/2 activates the transcription factor C/EBPa (3) and represses the expression of Nr1d1
(REV-ERBa). (4) NR1D1 represses the transcription of Nfil3, which is a (5) repressor of Rorc. Thus, melatonin signaling releases the inhibition of Nfil3 by NR1D1
and results in the suppression of Rorc.
(B) A representation of various environmental cues regulating the balance between proinflammatory Th17 cells and immunosuppressive Treg/Tr1 cells.relapse rates during spring and summer
months, when UV rays are most abun-
dant. In order to understand the environ-
mental factors impacting the seasonal
pattern of MS relapses, Farez et al.
(2015) hypothesize that melatonin pro-
duction, which also follows seasonal
variation, may be involved in MS disease.
Following up on a cohort of MS patients,
the authors identify a negative correlation
between clinical relapse and melatonin
levels, with the highest levels of mela-
tonin and the lowest exacerbation rate
during the winter months. Indeed, serum
from relapsing-remitting MS patients
shows a negative correlation between
the levels of melatonin and the proinflam-
matory cytokine IL-17 and a positive cor-
relation with the anti-inflammatory cyto-
kine IL-10. In vitro, the addition of
melatonin suppresses the polarization of
human T helper cells into the Th17 line-
age, resulting in diminished expression
of the Th17 master transcription regu-
lator RORC and production of IL-17. In
addition to its negative impact on Th17
differentiation, melatonin also enhances
the polarization of type 1 regulatory cells
(Tr1), which can suppress immune re-
sponses through the production of IL-
10. Through a series of carefully de-
signed experiments with mice genetically
deficient in different components along
the melatonin signaling pathway, the au-
thors find that melatonin-dependent rein-
forcement of NFIL3, a negative regulator
of Rorc, suppresses the development ofTh17 cell in murine cells, while activation
of RORa boosts the Tr1cell fate.
Melatonin signals through the mem-
brane melatonin receptor (MTNR1A) that
is expressed on a variety of cell types,
including T cells. Both melatonin and the
small molecule agomelatine, a MTNR1A
agonist, repress the differentiation of
murine Th17 cells in vitro, resulting in the
suppression of key Th17 signature genes,
Rorc, Il17, and Il23r. Importantly, T cells
from MTNR1A KO mice are resistant to
the suppressive impact of melatonin in
Th17 cell differentiation, arguing that the
membrane melatonin receptor is critical
to mediate the effects of melatonin in
Th17 cell polarization. What is the molec-
ular mechanism of melatonin-dependent
inhibition of Th17 cells? The key to
answering this question is based on a
previous report (Yu et al., 2013) demon-
strating an important contribution of
REV-ERBa, a transcriptional repressor
with key regulatory functions in the control
of the circadian cycle, in promoting Th17
cell development, thus linking the circa-
dian clock with Th17 cell development.
Here is where the story gets complicated.
Melatonin increases the activation of Erk
1/2 which in turn leads to an increase in
the phosphorylation of the transcription
factor C/EBPa. C/EBPa binds to the pro-
moter of Nr1d1 (REV-ERBa) and acts as
a negative regulator. Confirming the regu-
latory function of REV-ERBa in Nfil3,
melatonin suppression of Nr1d1 expres-
sion results in increased NFIL3 bindingCell 162, Septo the Rorc promoter, leading to reduced
expression of Rorc (Figure 1A). In a com-
plementary set of experiments, the au-
thors find that melatonin signaling also
enhances in vitro Tr1 cell polarization,
increases IL-10 production, and boosts
the suppressive ability of these cells.
Melatonin increases binding of RORa
to the Il10 promoter, which synergizes
with AHR and c-Maf to enhance Il10
expression. Taken together, melatonin
shifts the balance from pathogenic Th17
cells to favor the immunosuppressive
Tr1 cells. Importantly, administration of
melatonin in a mouse model of MS leads
to amelioration of disease. Melatonin
reduces the frequency of Th17 cells
infiltrating the central nervous system,
particularly the pathogenic IL-17-IFNg
and IL-17-GMCSF double-positive cells,
while concomitantly increasing IL-10
producing immunosuppressive Tr1 cells
in the mouse model.
Over the past 50 years, there has been
a steady rise in the incidence of autoim-
mune diseases such as MS, RA, psoria-
sis, and IBD, particularly in developed
countries. Recent studies have uncov-
ered many environmental stress factors
associated with the modern life contrib-
uting to the development of inflammatory
disorders (Figure 1B). One example is the
‘‘high-salt’’ Western diet, where SGK1 on
Th17 cells play a role in exacerbating
T cell inflammatory mechanisms (Wu
et al., 2013). It is tempting to speculate
whether the invention of artificialtember 10, 2015 ª2015 Elsevier Inc. 1213
lights—which facilitates chronic circa-
dian disruptions—could have contributed
to an imbalance between the inflamma-
tory and regulatory responses of the im-
mune system, leading to immune dysre-
gulation. The current study establishes
a clear link between melatonin, a hor-
mone involved in the regulation of the
circadian rhythm, and the inhibition of
proinflammatory Th17 cells, thereby
shifting the balance of the immune
response toward immunosuppression.
These findings support the immunosup-
pressive properties of melatonin, as well
as define the melatonin-NFIL3-RORgt
pathway as a potential therapeutic target
for the treatment of MS.1214 Cell 162, September 10, 2015 ª2015 ElACKNOWLEDGMENTS
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In mechanotransduction, sensory receptors convert force into electrical signals to mediate such
diverse functions as touch, pain, and hearing. In this issue of Cell, Zhang et al. present evidence
that the fly NompC channel senses mechanical stimuli using its N-terminal tail as a tether between
the cell membrane and microtubules.As far back as Aristotle, the sense of
touch was valued, along with hearing,
sight, smell, and taste, as one of
the ‘‘five outward wits’’ central to the
human experience. It is now clear that
‘‘touch’’ is not merely a core aspect
of perception but represents a highly
specialized, diverse, and complex series
of sensory systems. Mechanosensation
plays an important role not just in feeling
objects and textures but also in eliciting
pain or pleasure, detecting sounds, and
sensing balance and the position of our
own bodies. In this issue of Cell, Zhang
et al. (2015) explore themolecular mecha-
nisms of mechanosensory transduction,
a process in which molecules in cell
membranes convert mechanical forcesinto electrical signals (Zhang et al.,
2015). They present a strong case that
the Drosophila NompC ion channel
senses mechanical stimuli using its N-ter-
minal tail as a tether between the cell
membrane and the microtubules of the
cytoskeleton (Figure 1).
Although numerous mechanosensing
ion channels have been identified, the
mechanisms by which force-to-signal
conversions occur remain unclear in
many cases (Anishkin et al., 2014). The
rapid activation kinetics of mechano-
sensing channels, seemingly too rapid
for second messenger generation, sug-
gests they are gated directly by mechani-
cal forces acting on the plasma mem-
brane. Two non-exclusive models forforce-activation of channels have been
proposed. In the membrane force model,
pressure on the plasma membrane alters
its shape and/or surface area, causing
opening of the embedded protein chan-
nel. On the other hand, the tether model
posits that molecular tethers convey force
between the channel and the cytoskel-
eton or extracellular milieu. Although
several examples of membrane force-
activated channels exist, notably the bac-
terial MscL channel, there has been no
direct molecular evidence supporting a
tether model (Anishkin et al., 2014).
Zhang et al. (2015) focus on the
Drosophila Transient Receptor Potential
(TRP) channel NompC. Cation channels
of the TRP family have long been
